Chief Financial Officer and Director

Ms. Nielsen played a role in the formation of WishBone Medical by assisting with the original WishBone Medical business plan. Since then, Dawn has been working with the WishBone Team in areas of finance and business development. Her activities include conducting valuation analysis for potential mergers & acquisitions, preparing materials to be presented to the Board of Investors including private placement memorandums, due diligence materials, investor presentations, and conducting competitive analysis.

Dawn has a vast resume that includes extensive merger and acquisition experience from her tenure on Wall Street with JP Morgan. In addition, her skill set arsenal is also complimented by her experience in the energy industry during the privatization of government utilities in Brazil and Argentina. Dawn has executed key deals including the sale of a subsidiary of Bristol Myers Squibb to Deltagen; the sale of Williams Pipeline Central to AIG Highstar; the sale of Southern Union Company’s Texas assets to Oneok; and the sale of CFLCL (Brazilian utility) to CMS Energy. She has also prepared and presented her findings to the Board of Directors of several Fortune 500 companies.

Dawn received her MBA from The Wharton School and her BSE from University of Michigan.